Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls.

about

Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls.

Item

http://www.wikidata.org/entity/Q55718024

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Soluble amyloid-beta buffering ...... ersus high-pathology controls.

@en

Soluble amyloid-beta buffering ...... ersus high-pathology controls.

@nl

type

Item

label

Soluble amyloid-beta buffering ...... ersus high-pathology controls.

@en

Soluble amyloid-beta buffering ...... ersus high-pathology controls.

@nl

prefLabel

Soluble amyloid-beta buffering ...... ersus high-pathology controls.

@en

Soluble amyloid-beta buffering ...... ersus high-pathology controls.

@nl

P1476

Soluble amyloid-beta buffering ...... ersus high-pathology controls.

@en

P2093

David L Brody

http://www.w3.org/2001/XMLSchema#string

Mihika Gangolli

http://www.w3.org/2001/XMLSchema#string

Nigel J Cairns

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism.

Solution state characterization of amyloid beta-derived diffusible ligands.

Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy.

Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration.

Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β

P304

e0200251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0200251

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas J Esparza

P577

2018-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29979775

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

dementia

P932

6034844

http://www.w3.org/2001/XMLSchema#string